Uncategorized

3Daughters Secures $4.7M in Seed Round to Advance Innovative IUD Development

3Daughters, a clinical development company dedicated to advancing women’s healthcare, has announced the successful completion of an oversubscribed seed financing round, raising $4.7 million. This round saw participation from existing investors including Thairm Bio, Argosy Foundation, Wexford Science and Technology, UMass Amherst, and new undisclosed investors. Mary Beth Cicero, CEO of 3Daughters, commented: “We are thrilled by the overwhelming response from both…

Chinese Medtech Company Landing Med Surpasses 10 Million AI-Assisted Pap Smear Screenings

Landing Med, a Chinese medtech company focused on early cancer detection, has achieved a significant milestone by completing over 10 million cervical cancer screenings using artificial intelligence (AI). Established by Dr. Xiaorong Sun, the company has been integrating automation, digital, AI, and cloud computing technologies into Pap smear testing across China since 2017. “I started Landing Med to address the challenge of…

Granata Bio Raises $14M in Series A Funding to Enhance Fertility Treatment Options

Granata Bio, a biopharma company specializing in fertility medications, has announced the closure of a $14 million Series A funding round. Led by GV (Google Ventures), this funding round includes significant contributions from CooperSurgical, Gedeon Richter, Alumni Ventures, Amboy Street Ventures, Vibe Bio, and others. The investment aims to accelerate the development of Granata Bio’s fertility biopharma pipeline, addressing a critical gap…

Diana Health Raises $34M in Series B Funding to Scale Its Maternity Care Model in the US

Diana Health, a network of modern women’s health practices that partner with hospitals to reimagine the way women’s healthcare is delivered, today announced that it has closed $34M in Series B financing led by Norwest Venture Partners. Existing investors .406 Ventures, LRVHealth and AlleyCorp joined the round, bringing the total raised to $46 million. The company will use the new capital to…

GE HealthCare Secures a $44M Gates Foundation Grant to Develop AI-Assisted Ultrasound Technology for Maternal and Pediatric Care

MedTech company GE HealthCare has been awarded a grant of more than $44M by the Bill & Melinda Gates Foundation. The funding will accelerate the development of AI-assisted ultrasound tools designed to improve healthcare outcomes in low-and-middle-income countries. Specifically, the grant will focus on creating AI-powered applications to aid healthcare professionals in obtaining more accurate ultrasound scans for maternal and fetal health…

Myma Medical Raises £145K from LYVA Labs to Take Its AI-based Fertility Technology to Market

Fertility startup Myma Medical has secured an additional £145K from innovation management consultancy LYVA Labs. bringing LYVA Labs’ total support for the UK-based startup to £779K, including grant leverage. Founded as a spinout from the University of Birmingham, Myma Medical is advancing fertility treatments with its patented autoICSI (Intracytoplasmic Sperm Injection) system. The next-gen technology aims to minimize inconsistencies that often occur…

What’s New in Femtech This Week? (Sep 7, 2023)

Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page. Highlights UK-based bladder care startup Jude adds $4.24M in seed funding setting sights on U.S. market. Pumpspotting secures $2.2M in funding to advance breastfeeding support in workplaces and beyond. Miri raises $1.2M in…

Palatin Technologies Partners with UpScriptHealth to Ease Access to HSDD Treatment Vyleesi

Palatin Technologies has announced a partnership with telehealth service provider UpScriptHealth. The collaboration aims to raise awareness about hypoactive sexual desire disorder (HSDD) and increase the accessibility of Vyleesi through UpScriptHealth’s Women’s Health Platform. According to the company Vyleesi is the only FDA-approved, as-needed treatment for acquired, generalized HSDD in premenopausal women. The partnership will make Vyleesi available to UpScriptHealth’s extensive patient…